ライフサイエンスコーパス: congenital deafness

1 sory experience, tinnitus would not exist in congenital deafness.

2 r-order auditory cortex remained auditory in congenital deafness.

3 rise to disorders of the cardiac rhythm and congenital deafness.

4 manifested as both retinitis pigmentosa and congenital deafness.

5 ms (DFNB) account for most cases of profound congenital deafness.

6 altzer locus result in circling behavior and congenital deafness.

7 me, which causes both cardiac arrhythmia and congenital deafness.

8 ly occurring cochlear pathology presented by congenital deafness.

9 9, one of the most frequent genetic forms of congenital deafness.

10 by the sensory hair cells of the ear, causes congenital deafness.

11 logical treatment is currently available for congenital deafness.

12 r, but also provide new candidates for human congenital deafness.

13 ry cortex remained unchanged in animals with congenital deafness.

14 In congenital deafness, a previous inactivation study docum

15 Many genetic forms of congenital deafness affect the sound reception antenna o

16 Mutations in human KCNE1 cause congenital deafness and congenital long QT syndrome, an

17 ments of the vasculature in animal models of congenital deafness and ischemic stroke, revealing that

18 ore comprehensive approach for management of congenital deafness and prevention of ototoxicity.

19 sher syndrome type 1C (USH1C), a syndrome of congenital deafness and progressive blindness, as well a

20 disorder characterized by moderate to severe congenital deafness and progressive retinitis pigmentosa

21 Both mutations cause congenital deafness and severe balance deficits due to i

22 into thyroid physiology, the pathogenesis of congenital deafness and the role of altered sulphate tra

23 rited disorder with the hallmark features of congenital deafness and thyroid goitre.

24 ielsen syndrome type 2 (JLNS2), resulting in congenital deafness and vestibular dysfunction.

25 Usher syndrome is characterized by congenital deafness associated with retinitis pigmentosa

26 study demonstrates differences in effects of congenital deafness between supragranular and other cort

27 for several months, providing evidence that congenital deafness can be effectively overcome by treat

28 Congenital deafness causes large changes in the auditory

29 ause Usher syndrome (USH2D) and nonsyndromic congenital deafness (DFNB31).

30 en (Bth) mutant mice are models for profound congenital deafness (DFNB7/B11) and progressive hearing

31 Congenital deafness enhances responses of auditory corti

32 Pendred syndrome is a major cause of congenital deafness, goiter and defective iodide organif

33 Gene therapy for congenital deafness has shown promising results in child

34 ass XV unconventional myosin, cause profound congenital deafness in humans and both deafness and vest

35 ant mouse models for the most common form of congenital deafness in humans, which are knock-outs for

36 ant mouse models for the most common form of congenital deafness in humans, which are knockouts for t

37 odel for the most prevalent form of X-linked congenital deafness in man, which is associated with mut

38 The cause of the congenital deafness in Pendred syndrome is obscure, alth

39 development and are the most common cause of congenital deafness, it is not known if these variants d

40 dherin-15 gene (PCDH15), is characterized by congenital deafness, lack of balance, and progressive bl

41 Congenital deafness leads to atypical organization of th

42 Congenital deafness leads to functional deficits in the

43 SH1B) is a devastating genetic disorder with congenital deafness, loss of balance, and blindness caus

44 and E, resulted in cochlear degeneration and congenital deafness of Lrrc8a(-/-) mice.

45 py from cohorts of cats with normal hearing, congenital deafness, or congenital deafness with a cochl

46 animal models and humans have indicated that congenital deafness produces degenerative changes in the

47 Congenital deafness results in abnormal synaptic structu

48 Congenital deafness results in synaptic abnormalities in

49 ereditary disorder characterized by profound congenital deafness, retinitis pigmentosa, and vestibula

50 ically heterogeneous disorder causing severe congenital deafness, retinitis pigmentosa, and vestibula

51 Prevalence of mutations in the GJB2 gene by congenital deafness status.

52 l impact on cells in the cochlear nucleus to congenital deafness, suggesting selective processing imp

53 e show in a new mouse model of Gjb2-mediated congenital deafness that cochlear supporting cells adjac

54 Individuals with congenital deafness that have received gene therapy repr

55 ion have been studied using animal models of congenital deafness that include surgical ablation of th

56 ion factor 1 (Pit1(dw)), which has profound, congenital deafness that is rescued by oral TH replaceme

57 r syndrome type 1, characterized by profound congenital deafness, vestibular arreflexia, and progress

58 a recessive autosomal disorder manifested by congenital deafness, vestibular dysfunction, and progres

59 type 1B (USH1B), a disease characterized by congenital deafness, vision loss, and balance impairment

60 The deaf white cat, a proven model of congenital deafness, was used to examine how deafness an

61 not only in early detection and diagnosis of congenital deafness, which triggers intervention, but al

62 with normal hearing, congenital deafness, or congenital deafness with a cochlear implant.

63 mutation can be offered to individuals with congenital deafness with high sensitivity and specificit

64 Cosegregation of profound, congenital deafness with markers on chromosome 6q13 in t

65 , Pendred first described the association of congenital deafness with thyroid goitre (MM#274600).